Project Details
Description
A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101
| Status | Finished |
|---|---|
| Effective start/end date | 1/18/12 → 11/22/12 |
Funding
- PHARMANET, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.